GLICLAZIDE GH MR gliclazide 60 mg modified release tablet blister pack

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Aktivna sestavina:

gliclazide, Quantity: 60 mg

Dostopno od:

Lupin Australia Pty Limited

Farmacevtska oblika:

Tablet, modified release

Sestava:

Excipient Ingredients: hypromellose; povidone; calcium hydrogen phosphate dihydrate; magnesium stearate

Pot uporabe:

Oral

Enote v paketu:

20 tablets, 60 tablets

Tip zastaranja:

(S4) Prescription Only Medicine

Terapevtske indikacije:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Povzetek izdelek:

Visual Identification: White to off-white oval shaped, bioconvex, uncoated tablet with a break line on both sides and debossed wtih 60 on one side of the break line on one surface.and plain on the other side; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Status dovoljenje:

Registered

Datum dovoljenje:

2022-11-14